Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin's Lymphoma
- 1 August 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 169 (2) , 655-664
- https://doi.org/10.2353/ajpath.2006.060020
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell developmentBlood, 2005
- Id family of helix-loop-helix proteins in cancerNature Reviews Cancer, 2005
- Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2Blood, 2005
- Id2 Is Dispensable for Myc-Induced LymphomagenesisCancer Research, 2004
- Id2 Drives Differentiation and Suppresses Tumor Formation in the Intestinal EpitheliumCancer Research, 2004
- Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β HeterodimerCell, 2004
- Receptor Editing and Marginal Zone B Cell Development Are Regulated by the Helix-Loop-Helix Protein, E2AThe Journal of Experimental Medicine, 2004
- Gene expression profiling reveals a highly specialized genetic program of plasma cellsBlood, 2003
- The regulation and function of the Id proteins in lymphocyte developmentOncogene, 2001
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999